Abstract
OBJECTIVE: To substantiate in a premenopausal population of women, the link between visceral adipose tissue and circulating plasminogen activator inhibitor 1 (PAI-1) levels.
DESIGN: Study of correlations between anthropometric parameters and PAI-1 and evaluation of the changes induced by weight loss.
SUBJECTS: Forty-two healthy pre-menopausal women (aged 18–51 y, with a wide range of body mass index (BMI, 21–48.8 kg/m2). Thirteen women were evaluated after weight loss (6.6±3.3 kg).
MEASUREMENTS: BMI, waist and hip circumferences. Total, subcutaneous and visceral adipose tissue areas at the L3–L4 level by computed tomography. Insulin, cholesterol, triglyceride, HDL cholesterol, PAI-1 activity, PAI-1 antigen and tissue plasminogen activator (tPA) antigen.
RESULTS: PAI-1 activity, PAI antigen and tPA antigen were positively correlated with visceral adipose tissue, but not with subcutaneous adipose tissue. This correlation was independent of insulin or triglyceride levels. The amount of visceral adipose tissue explained 28% of the PAI-1 activity variance.
Weight loss confirmed this link, PAI-1 diminution being correlated only with visceral adipose tissue loss and not with total fat, insulin or triglyceride decrease.
CONCLUSION: This study suggests, like in vitro studies, that visceral fat may be an important contributor to the circulating PAI-1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Janand-Delenne, B., Chagnaud, C., Raccah, D. et al. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women. Int J Obes 22, 312–317 (1998). https://doi.org/10.1038/sj.ijo.0800585
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0800585
Keywords
This article is cited by
-
Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies
Scientific Reports (2016)
-
Prothrombotic markers in asymptomatic dyslipidemic subjects
Journal of Thrombosis and Thrombolysis (2011)
-
Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?
Diabetologia (2007)
-
Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes
Current Diabetes Reports (2006)
-
Treatment of the metabolic syndrome: The impact of lifestyle modification
Current Atherosclerosis Reports (2005)